Articles
abbvie acquires cerevel to grow neuroscience drug offerings
AbbVie acquires Cerevel, expanding neuroscience portfolio with innovative treatments and therapies for neurodegenerative diseases and disorders.
Read More
abbvie autoimmune acquisition boosts immunology strength
AbbVie autoimmune acquisition boosts immunology portfolio with new treatments, expanding options for autoimmune disease patients.
Read More
abbvie allergan acquisition opens new pharma era
Discover how AbbVie Allergan acquisition transforms the pharma industry with innovative treatments, expanded portfolios, and strategic growth.
Read More
AbbVie Acquisition History: Key Deals That Shaped Its Growth
Explore abbvie acquisition history with clear, simple facts on key deals that shaped the company’s growth and success in healthcare and biotech.
Read More
Roche Genentech Acquisition Explained: What You Need to Know
Discover the Roche Genentech acquisition explained in simple terms. Learn about the deal, its impact, and what it means for the future of biotech.
Read More
AbbVie Acquisition of Cerevel Therapeutics Finalized
AbbVie completes acquisition of Cerevel Therapeutics, expanding neuroscience portfolio and advancing innovative treatments for brain disorders.
Read More